Virgilant is transforming chronic respiratory disease care.
Our world-leading, all-in-one Telehealth platform is comprised of “smart” inhalers, AI-enabled digital health solutions, and cloud-based patient triage & monitoring — improving patient outcomes, reducing healthcare costs, and expanding access to high-quality care — especially for underserved and rural populations.
About
Virgilant is redefining how chronic diseases are managed—starting with respiratory care.
Our integrated hardware-and-software platform pairs precision-engineered “smart” inhalers with advanced AI analytics to deliver personalized, data-driven care for asthma, COPD, and cystic fibrosis patients. The system reminds users when a dose is due, tracks adherence, and measures lung function through built-in spirometry sensors.
By closing this data loop, Virgilant’s platform can predict and help prevent exacerbations, evaluate treatment effectiveness, and support physicians with evidence-based insights.
The result: better outcomes for patients, fewer hospitalizations, and reduced healthcare costs.
Building on our success in respiratory care, we are expanding our medical device development and predictive-care models to other major chronic conditions, including diabetes and cardiovascular disease.
We aim to make high-quality care accessible to everyone—regardless of geography or income—while contributing to a deeper understanding of the diseases that impact humanity the most.
Virgil (Circa. 70 BC)